HOLX - Hologic, Inc.

Is Hologic, Inc. (HOLX) A Good Stock To Buy?

It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth […]

See what the IHS Markit Score report has to say about Hologic Inc.

Hologic Inc NASDAQ/NGS:HOLX

See what the IHS Markit Score report has to say about Hologic Inc.

Hologic Inc NASDAQ/NGS:HOLX

How Hologic Stock Has Fared in the Last Month

After rising from $36.53 on April 9, 2018, to $42.91 on July 31, 2018, Hologic (HOLX) stock slid to $37.90 on October 29, 2018. Subsequently, Hologic stock managed to rise to $44.51 on November 28, 2018. Hologic’s revenue grew by 1.32% from $802.9 million in the fourth quarter of 2017 to $813.5 million in the fourth quarter of 2018.

See what the IHS Markit Score report has to say about Hologic Inc.

The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

3 Big Stock Charts for Friday: Hologic, Newell Brands and Juniper Networks

The 2.6% advance from General Electric (NYSE:GE) shares on Thursday still wasn’t enough to get, and keep, the overall market out of the red. Although the index spent some time in profitable territory yesterday, by the time the closing bell rang the S&P 500 was down to the tune of 0.22%. Rather than GE, a few too many traders were taking their cues from Twitter (NYSE:TWTR) and Quest Diagnostics (NYSE:DGX).

Analysts Remain Bullish on Align Stock

In November 2018, of the total 15 analysts covering Align Technology (ALGN), 13 analysts have given Align stock a “buy” or higher rating, and two analysts have given it a “hold” rating. The mean rating for Align Technology stock is 1.67 with a target price of $317.36, implying an upside potential of 43.8% over Align Technology’s closing price of $220.71 on November 27, 2018.

See what the IHS Markit Score report has to say about Hologic Inc.

The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

What Analysts Recommend for Hologic Stock

In November 2018, of the total 20 analysts covering Hologic (HOLX), ten analysts have given the stock a “buy” or higher rating, and ten analysts have given it a “hold” rating. The mean rating for Hologic stock is 2.3 with a target price of $45.09, implying an upside potential of 8.5% over Hologic’s closing price of $41.54 on November 21, 2018.

How Does Hologic’s Operational Performance Look?

Hologic (HOLX) incurred general and administrative expenses of $366.1 million in fiscal 2018 as compared with $343.3 million in fiscal 2017. This increase was due to higher legal fees, costs for international infrastructure, and higher bad debt. Its selling and marketing expenses also increased from $498.6 million in fiscal 2017 to $544.6 million in fiscal 2018 due to Cynosure’s inclusion in Hologic’s activity.

A Look at Hologic’s Gross Margin Trend

Hologic’s (HOLX) cost of product revenues increased from $881.8 million in fiscal 2017 to $886.6 million in fiscal 2018. Its amortization on intangible assets increased from $297.1 million in fiscal 2017 to $319.4 million in fiscal 2018 due to an increase associated with the Cynosure acquisition partially offset by lower amortization expenses related to the sale of its blood screening business. The company’s gross margin contracted from 64.07% in fiscal 2017 to 62.72% in fiscal 2018.

How Hologic’s Revenue Is Trending

Hologic (HOLX) is a leading developer, manufacturer, and supplier of diagnostics products, medical imaging systems, surgical products, and treatment systems. The company operates in five segments: diagnostics, breast health, medical aesthetics, GYN surgical, and skeletal health.

3 Big Stock Charts for Wednesday: Coca-Cola, Hologic and Applied Materials

See what the IHS Markit Score report has to say about Hologic Inc.

The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

Hologic (HOLX) Q4 Earnings Miss, Revenues Top Estimates

Tough year-over-year comparisons and soft Diagnostics sales hurt Hologic's (HOLX) performance in Q4.

Hologic, Inc. (HOLX) Q4 2018 Earnings Conference Call Transcript

HOLX earnings call for the period ending September 30, 2018.

Hologic (HOLX) Misses Q4 Earnings Estimates

Hologic (HOLX) delivered earnings and revenue surprises of -1.69% and 1.04%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?